当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析 - 现金流量表

易瑞生物

(300942)

  

流通市值:45.00亿  总市值:45.00亿
流通股本:4.05亿   总股本:4.05亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金190,874,391.53117,461,879.8560,678,544.67227,748,709.79
  收到的税费返还14,381.914,381.9012,934,578.63
  收到其他与经营活动有关的现金15,396,217.7811,537,678.956,588,593.5217,597,868.67
  经营活动现金流入小计206,284,991.21129,013,940.767,267,138.19258,281,157.09
  购买商品、接受劳务支付的现金72,274,492.247,579,131.6327,327,577.3197,172,677.36
  支付给职工以及为职工支付的现金70,386,233.9248,033,025.3327,403,778.2283,379,778.47
  支付的各项税费2,384,748.321,680,684.621,248,847.73,340,489.36
  支付其他与经营活动有关的现金53,410,540.4131,741,451.5812,702,169.4340,130,009.3
  经营活动现金流出小计198,456,014.85129,034,293.1668,682,372.66224,022,954.49
  经营活动产生的现金流量净额7,828,976.36-20,352.46-1,415,234.4734,258,202.6
二、投资活动产生的现金流量:
  收回投资收到的现金20,598,934.48--37,661,616.16
  取得投资收益收到的现金4,976,290.473,707,966.251,762,483.793,463,334.43
  处置固定资产、无形资产和其他长期资产收回的现金净额29,329,300.381,004,606.63669,9001,230,360
  处置子公司及其他营业单位收到的现金净额359,143.42359,143.42359,143.42354,239.56
  收到的其他与投资活动有关的现金686,213,774.35377,213,774.35216,213,774.35718,795,004.49
  投资活动现金流入小计741,477,443.1382,285,490.65219,005,301.56761,504,554.64
  购建固定资产、无形资产和其他长期资产支付的现金32,164,358.9820,543,108.9116,141,862.48174,103,679.98
  投资支付的现金9,750,0007,150,0001,800,000-
  支付其他与投资活动有关的现金544,571,355.76229,571,355.7640,343,042.76934,918,090.47
  投资活动现金流出小计586,485,714.74257,264,464.6758,284,905.241,109,021,770.45
  投资活动产生的现金流量净额154,991,728.36125,021,025.98160,720,396.32-347,517,215.81
三、筹资活动产生的现金流量:
  吸收投资收到的现金240,000240,000240,0002,000,000
  其中:子公司吸收少数股东投资收到的现金240,000240,000240,0002,000,000
  取得借款收到的现金26,688,827.625,688,827.625,688,827.62108,818,522.1
  收到其他与筹资活动有关的现金---1,595,835.93
  筹资活动现金流入小计26,928,827.625,928,827.625,928,827.62112,414,358.03
  偿还债务支付的现金38,541,695.1336,094,463.423,727,231.7110,216,336.84
  分配股利、利润或偿付利息支付的现金12,552,852.9910,035,189.931,545,455.145,337,261.42
  其中:子公司支付给少数股东的股利、利润--0-
  支付其他与筹资活动有关的现金--09,721,964.07
  筹资活动现金流出小计51,094,548.1246,129,653.355,272,686.8525,275,562.33
  筹资活动产生的现金流量净额-24,165,720.5-40,200,825.73656,140.7787,138,795.7
四、汇率变动对现金及现金等价物的影响3,204,826.714,472,755.281,792,812.671,503,302.13
五、现金及现金等价物净增加额141,859,810.9389,272,603.07161,754,115.29-224,616,915.38
  加:期初现金及现金等价物余额257,131,959.42257,131,959.42257,131,959.42481,748,874.8
  期末现金及现金等价物余额398,991,770.35346,404,562.49418,886,074.71257,131,959.42
补充资料:
  净利润-1,889,832.3-16,619,408.29
  资产减值准备-781,587.6-10,184,622.46
  固定资产和投资性房地产折旧-10,822,484.9-11,658,015.8
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-10,822,484.9-11,658,015.8
  无形资产摊销-970,565.76-1,933,445.41
  长期待摊费用摊销-493,641.32-1,739,322.67
  处置固定资产、无形资产和其他长期资产的损失--171,594.88--2,283,492.87
  固定资产报废损失--52,820.68-1,109,521.34
  公允价值变动损失--1,704,458.31--1,871,304.38
  财务费用-8,351,020.95-18,666,370.68
  投资损失-2,323,090.92-5,849,539.02
  递延所得税--1,245,548.37-2,977,120.92
  其中:递延所得税资产减少--1,245,548.37-2,977,120.92
  存货的减少--12,281,469.91-20,298,109.65
  经营性应收项目的减少-3,370,358.86--20,850,509.75
  经营性应付项目的增加--11,875,686.92--58,743,753.18
  其他--1,691,356-19,264,541.97
  现金的期末余额-346,404,562.49-257,131,959.42
  减:现金的期初余额-257,131,959.42-481,748,874.8
  现金及现金等价物的净增加额-89,272,603.07--224,616,915.38
公告日期2025-10-282025-08-282025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑